Literature DB >> 35991483

Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CanHepC), the Canadian Association of Hepatology Nurses (CAHN), and the Canadian NASH Network 2022 Abstracts.

.   

Abstract

Entities:  

Year:  2022        PMID： 35991483      PMCID： PMC9236590          DOI： 10.3138/canlivj.5.2.abst

Source DB:  PubMed          Journal:  Can Liver J        ISSN： 2561-4444


× No keyword cloud information.
  55 in total

1.  Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.

Authors:  Meike H van der Ree; J Marleen de Vree; Femke Stelma; Sophie Willemse; Marc van der Valk; Svend Rietdijk; Richard Molenkamp; Janke Schinkel; Ad C van Nuenen; Ulrich Beuers; Salah Hadi; Marten Harbers; Eva van der Veer; Kai Liu; John Grundy; Amy K Patick; Adam Pavlicek; Jacqueline Blem; Michael Huang; Paul Grint; Steven Neben; Neil W Gibson; Neeltje A Kootstra; Hendrik W Reesink
Journal:  Lancet       Date:  2017-01-11       Impact factor: 79.321

2.  Curing chronic hepatitis C--the arc of a medical triumph.

Authors:  Raymond T Chung; Thomas F Baumert
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

3.  The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.

Authors:  Sofia R Bartlett; Amanda Yu; Nuria Chapinal; Carmine Rossi; Zahid Butt; Stanley Wong; Maryam Darvishian; Mark Gilbert; Jason Wong; Mawuena Binka; Maria Alvarez; Mark Tyndall; Mel Krajden; Naveed Z Janjua
Journal:  Liver Int       Date:  2019-09-20       Impact factor: 5.828

4.  Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Authors:  Javier Fernández; Joan Clària; Alex Amorós; Ferrán Aguilar; Miriam Castro; Mireia Casulleras; Juan Acevedo; Marta Duran-Güell; Laura Nuñez; Montserrat Costa; Mireia Torres; Raquel Horrillo; Luis Ruiz-Del-Árbol; Cándido Villanueva; Verónica Prado; Mireya Arteaga; Jonel Trebicka; Paolo Angeli; Manuela Merli; Carlo Alessandria; Niels Kristian Aagaard; German Soriano; François Durand; Alexander Gerbes; Thierry Gustot; Tania M Welzel; Francesco Salerno; Rafael Bañares; Victor Vargas; Agustin Albillos; Aníbal Silva; Manuel Morales-Ruiz; Juan Carlos García-Pagán; Marco Pavesi; Rajiv Jalan; Mauro Bernardi; Richard Moreau; Antonio Páez; Vicente Arroyo
Journal:  Gastroenterology       Date:  2019-03-22       Impact factor: 22.682

5.  Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease.

Authors:  Leonardo Calza; Vincenzo Colangeli; Marco Borderi; Simona Coladonato; Beatrice Tazza; Giacomo Fornaro; Lorenzo Badia; Viola Guardigni; Gabriella Verucchi; Pierluigi Viale
Journal:  Infect Dis (Lond)       Date:  2019-06-20

6.  Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.

Authors:  Manal M Hassan; Lu-Yu Hwang; Chiq J Hatten; Mark Swaim; Donghui Li; James L Abbruzzese; Palmer Beasley; Yehuda Z Patt
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

7.  Isolation of Particles of Recombinant ASC and NLRP3.

Authors:  Fátima Martín-Sánchez; Ana I Gómez; Pablo Pelegrín
Journal:  Bio Protoc       Date:  2015-05-20

8.  Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8+ T-Cells in Advanced Liver Disease.

Authors:  Agatha Vranjkovic; Felicia Deonarine; Shaima Kaka; Jonathan B Angel; Curtis L Cooper; Angela M Crawley
Journal:  Front Immunol       Date:  2019-08-13       Impact factor: 7.561

9.  miR-122-based therapies select for three distinct resistance mechanisms based on alterations in RNA structure.

Authors:  Jasmin Chahal; Luca F R Gebert; Carolina Camargo; Ian J MacRae; Selena M Sagan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 12.779

10.  Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study.

Authors:  George F Mells; Greta Pells; Julia L Newton; Andrew J Bathgate; Andrew K Burroughs; Michael A Heneghan; James M Neuberger; Darren B Day; Samantha J Ducker; Richard N Sandford; Graeme J Alexander; David E J Jones
Journal:  Hepatology       Date:  2013-07       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.